Oops, something went wrong
Key moments from company performance results.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the commercial building products industry, including AZZ (NYSE:AZZ) and its peers.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the semiconductors industry, including Seagate (NASDAQ:STX) and its peers.
Over the past six months, Nubank’s shares (currently trading at $14.55) have posted a disappointing 5.9% loss, well below the S&P; 500’s 4.8% gain. This might have investors contemplating their next move.
Over the last six months, Primerica’s shares have sunk to $257.38, producing a disappointing 5.2% loss - a stark contrast to the S&P; 500’s 4.8% gain. This might have investors contemplating their next move.
Shareholders of Inspire Medical Systems would probably like to forget the past six months even happened. The stock dropped 22.7% and now trades at $62.98. This may have investors wondering how to approach the situation.
The S&P; 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.
Oracle is set to report its latest quarterly results after the closing bell Tuesday. Traders anticipate the event could lead to a big move in the tech giant's stock.
Oracle will report its Q3 earnings after the bell on Tuesday.
Since March 2021, the S&P; 500 has delivered a total return of 76%. But one standout stock has more than doubled the market - over the past five years, W.W. Grainger has surged 186% to $1,112 per share. Its momentum hasn’t stopped as it’s also gained 11.8% in the last six months, beating the S&P; by 7%.
Monolithic Power Systems currently trades at $1,020 and has been a dream stock for shareholders. It’s returned 215% since March 2021, nearly tripling the S&P; 500’s 76% gain. The company has also beaten the index over the past six months as its stock price is up 19% thanks to its solid quarterly results.
Over the last six months, Dolby Laboratories’s shares have sunk to $65.28, producing a disappointing 9.7% loss - a stark contrast to the S&P; 500’s 4.8% gain. This may have investors wondering how to approach the situation.
